Cargando…

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas

Although checkpoint inhibitors have been approved in multiple cancers, they are still under investigation in soft tissue sarcoma (STS). We conducted a retrospective review to report the safety, efficacy, and prognostic factors related to checkpoint inhibitors in STS. A sequential cohort of metastati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monga, Varun, Skubitz, Keith M., Maliske, Seth, Mott, Sarah L., Dietz, Hilary, Hirbe, Angela C., Van Tine, Brian A., Oppelt, Peter, Okuno, Scott, Robinson, Steven, O’Connor, Madeline, Seetharam, Mahesh, Attia, Steven, Charlson, John, Agulnik, Mark, Milhem, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408640/ https://www.ncbi.nlm.nih.gov/pubmed/32664595 http://dx.doi.org/10.3390/cancers12071873

Ejemplares similares

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
por: Heater, Natalie K., et al.
Publicado: (2023)

Non-Conventional Treatments for Conventional Chondrosarcoma
por: Monga, Varun, et al.
Publicado: (2020)

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy
por: Miller, Devon, et al.
Publicado: (2022)

Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
por: Rytlewski, Jeff, et al.
Publicado: (2021)

Fatal pulmonary embolism following splenectomy in a patient with Evan’s syndrome: case report and review of the literature
por: Monga, Varun, et al.
Publicado: (2017)

Patient reported quality of life in young adults with sarcoma receiving care at a sarcoma center
por: Day, Jonathan R., et al.
Publicado: (2022)

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
por: Monga, Varun, et al.
Publicado: (2018)

Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States
por: Pollack, Seth M., et al.
Publicado: (2020)

Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance
por: Rytlewski, Jeff, et al.
Publicado: (2022)

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma
por: Van Tine, Brian A., et al.
Publicado: (2019)

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas
por: Rytlewski, Jeffrey D., et al.
Publicado: (2021)

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors
por: Skubitz, Keith M, et al.
Publicado: (2008)

Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trial
por: Monga, Varun, et al.
Publicado: (2021)

Targeted therapies for the treatment of soft tissue sarcoma
por: Fuchs, Jeffrey W., et al.
Publicado: (2023)

Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents
por: Callaghan, Cameron M., et al.
Publicado: (2020)

Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma
por: Van Tine, Brian A, et al.
Publicado: (2021)

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
por: Attia, Steven, et al.
Publicado: (2022)

Testosterone deficiency in men receiving immunotherapy for malignant melanoma
por: Peters, Madeline, et al.
Publicado: (2021)

Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
por: Savani, Malvi, et al.
Publicado: (2019)

Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas
por: Skubitz, Keith M, et al.
Publicado: (2014)

Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma
por: Skubitz, Keith M., et al.
Publicado: (2019)

Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events
por: Swami, Umang, et al.
Publicado: (2019)

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma
por: Villalobos, Victor M., et al.
Publicado: (2019)

The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis
por: Liu, Lawrence, et al.
Publicado: (2022)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Case of Soft Sarcoma of the Cerebellum
por: Steven, James
Publicado: (1870)

Redox active metals and H(2)O(2) mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models()
por: Schoenfeld, Joshua D., et al.
Publicado: (2017)

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
por: Udhrain, Ashish, et al.
Publicado: (2007)

A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy
por: Hirbe, Angela C., et al.
Publicado: (2018)

Patterns of Extrapulmonary Metastases in Sarcoma Surveillance
por: Hong, Zachery, et al.
Publicado: (2021)

Immune checkpoint inhibitor resistance in soft tissue sarcoma
por: Eulo, Vanessa, et al.
Publicado: (2022)

Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M, et al.
Publicado: (2022)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study
por: Laughlin, Brady S., et al.
Publicado: (2022)

CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
por: Kohlmeyer, Jordan L, et al.
Publicado: (2020)

Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M., et al.
Publicado: (2022)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma
por: Bui, Nam, et al.
Publicado: (2023)

Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma
por: Attia, Steven, et al.
Publicado: (2015)

Patched Homolog 1 (PTCH1) Mutation in a CIC-Rearranged Sarcoma: Lack of Response to the Smoothened (SMO) Vismodegib
por: Wu, David J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pfun239pnmml0nsd9e89378bbi